Comparison of autologous bone marrow mononuclear cells transplantation and mobilization by granulocyte colony-stimulating factor in experimental spinal injury

International Journal of Neuroscience

Volumn 122, Issue 12, 2012, Pages 723-733

  Guo, Xiaohe ^a   Bu, Xingyao ^a   Li, Zhiying ^a   Yan, Zhaoyue ^a   Jiang, Jindou ^b   Zhou, Zhilong ^a  

^a HENAN PROVINCIAL PEOPLE'S HOSPITAL   (China)

^b SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

BMMCs; G CSF; spinal cord injury; transplantation

Indexed keywords

BLOOD CLOTTING FACTOR 8; BRAIN DERIVED NEUROTROPHIC FACTOR; BROXURIDINE; GRANULOCYTE COLONY STIMULATING FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; CONTROLLED STUDY; ELECTROPHYSIOLOGY; EVOKED MUSCLE RESPONSE; EVOKED SOMATOSENSORY RESPONSE; IMMUNOHISTOCHEMISTRY; MONONUCLEAR CELL; NICK END LABELING; NONHUMAN; PROTEIN EXPRESSION; RAT; SPINAL CORD INJURY; STATISTICAL SIGNIFICANCE; STEM CELL MOBILIZATION;

ANALYSIS OF VARIANCE; ANIMALS; ANTIGENS, CD; APOPTOSIS; BONE MARROW TRANSPLANTATION; BRAIN-DERIVED NEUROTROPHIC FACTOR; BROMODEOXYURIDINE; DISEASE MODELS, ANIMAL; ELECTROENCEPHALOGRAPHY; EVOKED POTENTIALS, MOTOR; EVOKED POTENTIALS, SOMATOSENSORY; GLIAL FIBRILLARY ACIDIC PROTEIN; GRANULOCYTE COLONY-STIMULATING FACTOR; MALE; NEUROLOGIC EXAMINATION; PHOSPHOPYRUVATE HYDRATASE; RATS; RATS, SPRAGUE-DAWLEY; SPINAL CORD INJURIES; TRANSPLANTATION, AUTOLOGOUS;

EID: 84869858289     PISSN: 00207454     EISSN: 15635279     Source Type: Journal    
DOI: 10.3109/00207454.2012.716109     Document Type: Article

References (34)

1. McDonald JW, Sadowsky C. Spinal-cord injury. Lancet. 2002;359:417-25.
2. Schwartz G, Fehlings MG. Secondary injury mechanisms of spinal cord trauma: A novel therapeutic approach for the management of secondary pathophysiology with the sodium channel blocker riluzole. Prog Brain Res. 2002;137:177-90.
3. Amar AP, Levy ML. Pathogenesis and pharmacological strategies for mitigating secondary damage in acute spinal cord injury. Neurosurgery. 1999;44:1027-39;discussion 1039-40.
4. Kumar AA, Kumar SR, Narayanan R, Arul K, Baskaran M. Autologous bone marrow derived mononuclear cell therapy for spinal cord injury: A phase I/II clinical safety and primary efficacy data. Exp Clin Transplant. 2009;7:241-8.
5. Yoshihara T, Ohta M, Itokazu Y, Matsumoto N, Dezawa M, Suzuki Y, Taguchi A, Watanabe Y, Adachi Y, Ikehara S, Sugimoto H, Ide C. Neuroprotective effect of bone marrowderived mononuclear cells promoting functional recovery from spinal cord injury. J Neurotrauma. 2007;24:1026-36.
6. Akiyama Y, Radtke C, Honmou O, Kocsis JD. Remyelination of the spinal cord following intravenous delivery of bone marrow cells. Glia. 2002;39:229-36.
7. Iihoshi S, Honmou O, Houkin K, Hashi K, Kocsis JD. A therapeutic window for intravenous administration of autologous bone marrow after cerebral ischemia in adult rats. Brain Res. 2004;1007:1-9.
8. Boiret N, Rapatel C, Veyrat-Masson R, Guillouard L, Gu'Erin JJ, Pigeon P, Descamps S, Boisgard S, Berger MG. Characterization of nonexpanded mesenchymal progenitor cells from normal adult human bone marrow. Exp Hematol. 2005;33:219-25.
9. Harting M, Jimenez F, Pati S, Baumgartner J, Cox C Jr. Immunophenotype characterization of rat mesenchymal stromal cells. Cytotherapy. 2008;10:243-53.
10. Prabhakar S, Muthaian R, Chabbra R, Anand A. Analysis of homing potential of marrow-derived mononuclear cells in an experimentally-induced brain stroke mouse model. Brain Inj. 2010;24:1485-90.
11. Nakano-Doi A, Nakagomi T, Fujikawa M, Nakagomi N, Kubo S, Lu S, Yoshikawa H, Soma T, Taguchi A, Matsuyama T. Bone marrow mononuclear cells promote proliferation of endogenous neural stem cells through vascular niches after cerebral infarction. Stem Cells. 2010;28:1292-1302.
12. Sykov'a E, Homola A, Mazanec R, Lachmann H, Konr'adov'a SL, Kobylka P, P'adr R, Neuwirth J, Komrska V, V'avra V, Stul'ik J, Bojar M. Autologous bone marrow transplantation in patients with subacute and chronic spinal cord injury. Cell Transplant. 2006;15:675-87.
13. Chernykh ER, Stupak VV, Muradov GM, Sizikov MY, Shevela EY, Leplina OY, Tikhonova MA, Kulagin AD, Lisukov IA, Ostanin AA, Kozlov VA. Application of autologous bone marrow stem cells in the therapy of spinal cord injury patients. Bull Exp Biol Med. 2007;143:543-7.
14. Weaver CH, Buckner CD, Longin K, Appelbaum FR, Rowley S, Lilleby K, Miser J, Storb R, Hansen JA, Bensinger W. Syngeneic transplantation with peripheral blood mononuclear cells collected after the administration of recombinant human granulocyte colony-stimulating factor. Blood. 1993;82:1981-4.
15. Sheridan WP, Morstyn G, Wolf M, Dodds A, Lusk J, Maher D, Layton JE, Green MD, Souza L, Fox RM. Granulocyte colony-stimulating factor and neutrophil recovery after highdose chemotherapy and autologous bone marrow transplantation. Lancet. 1989;2:891-5.
16. Nishio Y, Koda M, Kamada T, Someya Y, Kadota R, Mannoji C, Miyashita T, Okada S, Okawa A, Moriya H, Yamazaki M. Granulocyte colony-stimulating factor attenuates neuronal death and promotes functional recovery after spinal cord injury in mice. J Neuropathol Exp Neurol. 2007; 66:724-31.
17. Kim BR, Shim JW, Sung DK, Kim SS, Jeon GW, Kim MJ, Chang YS, Park WS, Choi ES. Granulocyte stimulating factor attenuates hypoxic-ischemic brain injury by inhibiting apoptosis in neonatal rats. Yonsei Med J. 2008;49:836-42.
18. Solaroglu I, Tsubokawa T, Cahill J, Zhang JH. Anti-apoptotic effect of granulocyte-colony stimulating factor after focal cerebral ischemia in the rat. Neuroscience. 2006;143:965-74.
19. Inoue M, Honmou O, Oka S, Houkin K, Hashi K, Kocsis JD. Comparative analysis of remyelinating potential of focal and intravenous administration of autologous bone marrow cells into the rat demyelinated spinal cord. Glia. 2003;44:111-8.
20. Basso DM, Beattie MS, Bresnahan JC. Graded histological and locomotor outcomes after spinal cord contusion using the NYU weight-drop device versus transection. Exp Neurol. 1996;139:244-56.
21. Basso DM, Beattie MS, Bresnahan JC. A sensitive and reliable locomotor rating scale for open field testing in rats. J Neurotrauma. 1995;12:1-21.
22. BaiH, Suzuki Y,Noda T,Wu S,Kataoka K, Kitada M, Ohta M, Chou H, Ide C. Dissemination and proliferation of neural stem cells on the spinal cord by injection into the fourth ventricle of the rat: A method for cell transplantation. J Neurosci Methods. 2003;124:181-7.
23. Ziegler MD, Hsu D, Takeoka A, Zhong H, Ram'on-Cueto A, Phelps PE, Roy RR, Edgerton VR. Further evidence of olfactory ensheathing glia facilitating axonal regeneration after a complete spinal cord transection. Exp Neurol. 2011;229: 109-19.
24. Kerr CL, Letzen BS, Hill CM, Agrawal G, Thakor NV, Sterneckert JL, Gearhart JD, All AH. Efficient differentiation of human embryonic stem cells into oligodendrocyte progenitors for application in a rat contusion model of spinal cord injury. Int J Neurosci. 2010;120:305-13.
25. Nuwer MR. Spinal cord monitoring with somatosensory techniques. J Clin Neurophysiol. 1998;15:183-93.
26. Blight AR, Young W. Central axons in injured cat spinal cord recover electrophysiological function following remyelination by Schwann cells. J Neurol Sci. 1989;91:15-34.
27. Iihoshi S, Honmou O, Houkin K, Hashi K, Kocsis JD. A therapeutic window for intravenous administration of autologous bone marrow after cerebral ischemia in adult rats. Brain Res. 2004;1007:1-9.
28. Herrera JJ, Sundberg LM, Zentilin L, Giacca M, Narayana PA. Sustained expression of vascular endothelial growth factor and angiopoietin-1 improves blood-spinal cord barrier integrity and functional recovery after spinal cord injury. J Neurotrauma. 2010;27:2067-76.
29. Widenfalk J, Lipson A, Jubran M, Hofstetter C, Ebendal T, Cao Y, Olson L. Vascular endothelial growth factor improves functional outcome and decreases secondary degeneration in experimental spinal cord contusion injury. Neuroscience. 2003;120:951-60.
30. Ribeiro-Resende VT, Pimentel-Coelho PM, Mesentier-Louro LA, Mendez RM, Mello-Silva JP, Cabral-da-Silva MC, de Mello FG, de Melo Reis RA, Mendez-Otero R. Trophic activity derived from bone marrow mononuclear cells increases peripheral nerve regeneration by acting on both neuronal and glial cell populations. Neuroscience. 2009;159:540-9.
31. Li TS, Furutani A, Takahashi M, Ohshima M, Qin SL, Kobayashi T, Ito H, Hamano K. Impaired potency of bone marrow mononuclear cells for inducing therapeutic angiogenesis in obese diabetic rats. Am J Physiol Heart Circ Physiol. 2006;290:H1362-9.
32. Saito A, Tominaga T, Chan PH. Neuroprotective role of neurotrophins: Relationship between nerve growth factor and apoptotic cell survival pathway after cerebral ischemia. Curr Atheroscler Rep. 2005;7:268-73.
33. Sehara Y, Hayashi T, Deguchi K, Zhang H, Tsuchiya A, Yamashita T, Lukic V, Nagai M, Kamiya T, Abe K. Potentiation of neurogenesis and angiogenesis by G-CSF after focal cerebral ischemia in rats. Brain Res. 2007;1151: 142-9.
34. Choi JK, Kim KH, Park H, Park SR, Choi BH. Granulocyte macrophage-colony stimulating factor shows anti-apoptotic activity in neural progenitor cells via JAK/STAT5-Bcl-2 pathway. Apoptosis. 2011;16:127-34.